Rapid relief from hot flashes

ACTIVELLA® 1.0 mg/0.5 mg has been shown to provide rapid relief from moderate to severe hot flashes.4

ACTIVELLA® 1.0 mg/0.5 mg shown to cause rapid reduction in hot flashes in a 4 week period

In a 12-week, placebo-controlled trial, 92 postmenopausal women were randomized to receive placebo (n=34), 1 mg E2 (n=29), or ACTIVELLA® 1.0 mg/0.5 mg (n=29).

By week 2, postmenopausal women taking ACTIVELLA® 1.0 mg/0.5 mg saw a 58% reduction in hot flashes.4 By week 4, postmenopausal women taking ACTIVELLA® 1.0 mg/0.5 mg saw a 90% reduction in hot flashes.4

PreviousNext

Important Safety Information

REFERENCES:

  • 4. Data on file. Study report/KLIM/PD/9/USA. Novo Nordisk Inc, Princeton, NJ.